Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $5,200 | 1 | 59.5% |
| Travel and Lodging | $1,631 | 3 | 18.7% |
| Unspecified | $1,171 | 6 | 13.4% |
| Food and Beverage | $736.31 | 6 | 8.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LivaNova USA, Inc. | $7,472 | 8 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,171 | 6 | $0 (2019) |
| Omniscient Neurotechnology America Ltd | $52.00 | 1 | $0 (2021) |
| Biogen, Inc. | $43.39 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,220 | 5 | LivaNova USA, Inc. ($7,220) |
| 2022 | $147.50 | 2 | LivaNova USA, Inc. ($104.11) |
| 2021 | $199.80 | 3 | LivaNova USA, Inc. ($147.80) |
| 2019 | $1,171 | 6 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($1,171) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/18/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Honoraria | Cash or cash equivalent | $5,200.00 | General |
| Category: Neurology | ||||||
| 03/18/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Travel and Lodging | Cash or cash equivalent | $1,282.20 | General |
| Category: Neurology | ||||||
| 03/18/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | In-kind items and services | $389.01 | General |
| Category: Neurology | ||||||
| 03/18/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Travel and Lodging | Cash or cash equivalent | $288.22 | General |
| Category: Neurology | ||||||
| 03/18/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Travel and Lodging | Cash or cash equivalent | $60.49 | General |
| Category: Neurology | ||||||
| 11/02/2022 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $43.39 | General |
| 09/14/2022 | LivaNova USA, Inc. | VNS Therapy Symmetry Model 8103 Generator (Device) | Food and Beverage | In-kind items and services | $104.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/08/2021 | LivaNova USA, Inc. | VNS - Symmetry (Device) | Food and Beverage | In-kind items and services | $109.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2021 | Omniscient Neurotechnology America Ltd | Quicktome (Device) | Food and Beverage | Cash or cash equivalent | $52.00 | General |
| Category: Software as a Medical Device | ||||||
| 11/30/2021 | LivaNova USA, Inc. | VNS - Symmetry (Device) | Food and Beverage | In-kind items and services | $38.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/05/2019 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | — | In-kind items and services | $201.71 | Research |
| Study: Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD | ||||||
| 10/05/2019 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | — | In-kind items and services | $121.99 | Research |
| Study: Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD | ||||||
| 10/05/2019 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | — | Cash or cash equivalent | $84.33 | Research |
| Study: Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD | ||||||
| 10/05/2019 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | — | In-kind items and services | $50.00 | Research |
| Study: Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD | ||||||
| 10/04/2019 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | — | In-kind items and services | $588.96 | Research |
| Study: Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD | ||||||
| 10/04/2019 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | — | In-kind items and services | $124.48 | Research |
| Study: Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD | Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,171 | 6 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 23 | 177 | $46,374 | $14,381 |
| 2022 | 1 | 22 | 172 | $45,064 | $14,410 |
| 2021 | 1 | 21 | 187 | $48,994 | $15,380 |
| 2020 | 2 | 40 | 290 | $76,820 | $25,751 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90870 | Therapy using electrical currents | Facility | 2023 | 23 | 177 | $46,374 | $14,381 | 31.0% |
| 90870 | Therapy using electrical currents | Facility | 2022 | 22 | 172 | $45,064 | $14,410 | 32.0% |
| 90870 | Shock treatment and monitoring | Facility | 2021 | 21 | 187 | $48,994 | $15,380 | 31.4% |
| 90870 | Shock treatment and monitoring | Facility | 2020 | 25 | 275 | $72,050 | $24,071 | 33.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 15 | 15 | $4,770 | $1,679 | 35.2% |
About Dr. Peter Rosenquist, MD
Dr. Peter Rosenquist, MD is a Psychiatry healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1033193099.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Rosenquist, MD has received a total of $8,739 in payments from pharmaceutical and medical device companies, with $7,220 received in 2024. These payments were reported across 16 transactions from 4 companies. The most common payment nature is "Honoraria" ($5,200).
As a Medicare-enrolled provider, Rosenquist has provided services to 106 Medicare beneficiaries, totaling 826 services with total Medicare billing of $69,921. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Augusta, GA
- Active Since 12/02/2005
- Last Updated 09/23/2014
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1033193099
Products in Payments
- VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) $7,220
- VNS - Symmetry (Device) $147.80
- VNS Therapy Symmetry Model 8103 Generator (Device) $104.11
- Quicktome (Device) $52.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Augusta
Joseph Mcevoy, Md, MD
Psychiatry — Payments: $113,605
Dr. William Mccall, Md, MD
Psychiatry — Payments: $69,198
Mary Tyson, M.d, M.D
Psychiatry — Payments: $15,524
Dr. Prakash Merai, M.d, M.D
Psychiatry — Payments: $13,057
Elizabeth Messulam, Md, MD
Psychiatry — Payments: $11,031
Dr. Brian Miller, M.d, M.D
Psychiatry — Payments: $9,544